To induce both STAT3 and NF-κB activation, human DU145 prostate cancer cells and murine B16 melanoma cells were stimulated with human and mouse type I IFN, respectively, a potent activator of these signaling pathways [15], [21]. The gene discussed is STAT3; the disease is melanoma.